A Microport Neuro announcement expects first-half revenue to reach 400 million to 410 million yuan, an increase of about 34% to 37% year-on-year. Revenue growth is mainly attributed to breakthroughs in overseas business, with revenue expected to increase by about 70% to 90%; an increase in market share of intracranial atherosclerotic stenosis products; spring coil products benefiting from winning centralized procurement bids, accelerating the development of blank markets; and the accelerated hospital access and clinical use of multiple acute ischemic stroke and pathway products.
Ver original
Esta página pode conter conteúdo de terceiros, que é fornecido apenas para fins informativos (não para representações/garantias) e não deve ser considerada como um endosso de suas opiniões pela Gate nem como aconselhamento financeiro ou profissional. Consulte a Isenção de responsabilidade para obter detalhes.
MicroBrain Science: Prevê-se um aumento da receita de cerca de 34% a 37% em relação ao mesmo período do ano anterior
A Microport Neuro announcement expects first-half revenue to reach 400 million to 410 million yuan, an increase of about 34% to 37% year-on-year. Revenue growth is mainly attributed to breakthroughs in overseas business, with revenue expected to increase by about 70% to 90%; an increase in market share of intracranial atherosclerotic stenosis products; spring coil products benefiting from winning centralized procurement bids, accelerating the development of blank markets; and the accelerated hospital access and clinical use of multiple acute ischemic stroke and pathway products.